Indomethacin for Post-ERCP Pancreatitis
Source:R/data-documentation.R
post_ercp_pancreatitis_tbl_df.RdThis dataset, post_ercp_pancreatitis_tbl_df, is a tibble containing results from a randomized, placebo-controlled, prospective 2-arm trial of rectal indomethacin (100 mg) versus placebo to prevent post-ERCP pancreatitis in 602 participants, as reported by Elmunzer, Higgins, et al. (2012) in the New England Journal of Medicine.
Usage
data(post_ercp_pancreatitis_tbl_df)Format
A tibble with 602 observations and 33 variables:
- id
Numeric subject identifier
- site
Factor indicating study site (4 levels)
- age
Numeric age of the participant
- risk
Numeric risk score
- gender
Factor indicating gender (2 levels)
- outcome
Factor indicating study outcome (2 levels)
- sod
Factor indicating presence of sphincter of Oddi dysfunction (2 levels)
- pep
Factor indicating presence of post-ERCP pancreatitis (2 levels)
- recpanc
Factor indicating recurrent pancreatitis (2 levels)
- psphinc
Factor indicating pancreatic sphincterotomy (2 levels)
- precut
Factor indicating precut sphincterotomy (2 levels)
- difcan
Factor indicating difficult cannulation (2 levels)
- pneudil
Factor indicating pneumatic dilation (2 levels)
- amp
Factor indicating ampullary interventions (2 levels)
- paninj
Factor indicating pancreatic injury (2 levels)
- acinar
Factor indicating acinarization (2 levels)
- brush
Factor indicating brushing procedures (2 levels)
- asa81
Factor indicating ASA 81 mg use (3 levels)
- asa325
Factor indicating ASA 325 mg use (3 levels)
- asa
Factor indicating ASA status (3 levels)
- prophystent
Factor indicating prophylactic stent placement (2 levels)
- therastent
Factor indicating therapeutic stent use (2 levels)
- pdstent
Factor indicating pancreatic duct stent (2 levels)
- sodsom
Factor indicating somatostatin use for SOD (2 levels)
- bsphinc
Factor indicating biliary sphincterotomy (2 levels)
- bstent
Factor indicating biliary stent (2 levels)
- chole
Factor indicating cholecystectomy (2 levels)
- pbmal
Factor indicating presence of pancreaticobiliary malignancy (2 levels)
- train
Factor indicating if performed by trainee (2 levels)
- status
Factor indicating trial status (2 levels)
- type
Factor indicating procedure type (4 levels)
- rx
Factor indicating treatment group: placebo or indomethacin (2 levels)
- bleed
Numeric bleeding indicator
Details
The dataset name has been kept as 'post_ercp_pancreatitis_tbl_df' to avoid confusion with other datasets in the R ecosystem. This naming convention helps distinguish this dataset as part of the DigestiveDataSets package and assists users in identifying its specific characteristics. The suffix 'tbl_df' indicates that the dataset is a tibble. The original content has not been modified in any way.